-
1
المؤلفون: J.-S. Frenel, A. Lusque, S. Delaloge, J.-M. Ferrero, T. Bachelot, I. Desmoulins, C. Levy, J.-C. Eymard, A. Gonçalves, A. Patsouris, M. A. Mouret Reynier, M. J.-C. Thery, T. Petit, L. Cabel, L. Uwer, M. Debled, M. Chevrot, A. Mailliez, W. Jacot, T. de La Motte Rouge
المصدر: British Journal of Cancer. 128:2072-2080
مصطلحات موضوعية: Cancer Research, Oncology
-
2Academic Journal
المؤلفون: P. Barthélémy, A. Thiery-Vuillemin, B. Escudier, J-C. Eymard, G. Mouillet, F. Schlürmann, M. Chartier, C. Quentric, Y-A. Vano, L. Albiges
المصدر: European Urology Open Science, Vol 21, Iss , Pp S182- (2020)
مصطلحات موضوعية: Diseases of the genitourinary system. Urology, RC870-923, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
3Academic Journal
المؤلفون: C. Marchand Crety, C. Garbar, G. Madelis, F. Guillemin, P. Soibinet Oudot, J. C. Eymard, S. Servagi Vernat
المصدر: Radiation Oncology, Vol 13, Iss 1, Pp 1-5 (2018)
مصطلحات موضوعية: Abrikossoff’s tumor, Granular cell tumor, Treatment, Medical physics. Medical radiology. Nuclear medicine, R895-920, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
4
المؤلفون: P. Barthelemy, C. Thibault, E. Voog, J-C. Eymard, A. Ravaud, A. Flechon, C. Abraham Jaillon, W. Hilgers, S. Le Moulec, M. Chasseray, D. Pouessel, Y.E. Amela, V. Lorgis, E. Nicolas, E. Kazan, G. Denechere, M-N. Solbes, P. Lambert, Y. Loriot
المصدر: Annals of Oncology. 33:S1341-S1342
مصطلحات موضوعية: Oncology, Hematology
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::fcb0f65bd5698d33a6b1ddd4303b28a2
https://doi.org/10.1016/j .annonc.2022.07.1835 -
5
المؤلفون: M. Bringuier, M. Carton, C. Levy, A. Patsouris, D. Pasquier, M. Debled, O. Rigal, W. Jacot, A. Gonçalves, I. Desmoulins, T. De La Motte Rouge, T. Bachelot, J.-M. Ferrero, J.-C. Eymard, M. Ung, M.-A. Mouret-Reynier, T. Petit, M. Chevrot, L. Uwer, C. Courtinard, J.-S. Frenel, A. Vianzone, C. Baldini
المصدر: Breast cancer research and treatment. 191(3)
مصطلحات موضوعية: Cohort Studies, Cancer Research, Oncology, Databases, Factual, Receptor, ErbB-2, Antineoplastic Combined Chemotherapy Protocols, Humans, Breast Neoplasms, Female, Neoplasms, Second Primary, Aged, Retrospective Studies
-
6
المؤلفون: Gaëtane Simon, C. Levy, Thomas Bachelot, M.A. Mouret Reynier, J.-C. Eymard, Lionel Uwer, A. Vasseur, T. de La Motte Rouge, Luc Cabel, Thomas Grinda, Florence Dalenc, A. Gonçalves, Isabelle Desmoulins, Matthieu Carton, Séverine Guiu, Paule Augereau, Thierry Petit, Laurence Vanlemmens, Marc Debled, M. Robert
المصدر: Annals of Oncology. 32:S501-S502
مصطلحات موضوعية: Oncology, medicine.medical_specialty, Taxane, Breast cancer, business.industry, Internal medicine, HER2 negative, medicine, Hematology, medicine.disease, Previously treated, business
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::6ca1935831769b075ebfa2b75ecbf3f7
https://doi.org/10.1016/j .annonc.2021.08.597 -
7
المؤلفون: P. Hamberg, P. Gajate Borau, Philippe Barthélémy, Michael Staehler, Giuseppe Procopio, Pierre Bigot, C. Suarez Rodriguez, J.-C. Eymard, Cristina Masini, P. Dutailly, Valerie Perrot
المصدر: Annals of Oncology. 32:S695-S696
مصطلحات موضوعية: Oncology, medicine.medical_specialty, biology, Cabozantinib, business.industry, VEGF receptors, medicine.medical_treatment, Hematology, medicine.disease, Targeted therapy, chemistry.chemical_compound, chemistry, Renal cell carcinoma, Interim, Internal medicine, medicine, biology.protein, In patient, Nivolumab, business
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::f737bd0550d390ad8eafbfc336a44b2d
https://doi.org/10.1016/j .annonc.2021.08.068 -
8
المؤلفون: Eric Voog, Frank Priou, J.-C. Eymard, Philippe Barthélémy, Ali Hasbini, Nicolas Penel, E. Bompas, C. Saldana, R. Longo, Pierre-Emmanuel Brachet, Hakim Mahammedi, Emeline Colomba, Remy Delva, Stéphanie Foulon, Delphine Borchiellini, Karim Fizazi, S.F. Jonas, Y. Neuzillet, Guilhem Roubaud, Carole Helissey
المصدر: Annals of Oncology. 32:S646-S647
مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, Castrate-resistant prostate cancer, Hematology, chemistry.chemical_compound, Darolutamide, chemistry, Internal medicine, medicine, Enzalutamide, Cognitive Assessment System, business
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::d86177f1680dcf743749f0604566afe9
https://doi.org/10.1016/j .annonc.2021.08.1116 -
9
المؤلفون: M. Leheurteur, Michaël Chevrot, Lionel Uwer, Luc Cabel, Thomas Bachelot, Anne Patsouris, Audrey Mailliez, William Jacot, J-M Ferrero, Thierry Petit, J.-C. Eymard, C. Levy, T. de La Motte Rouge, M.A. Mouret Reynier, Amélie Lusque, Suzette Delaloge, J-S. Frenel, Isabelle Desmoulins, Marc Debled, A. Gonçalves
المصدر: Annals of Oncology. 32:S458-S459
مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, Internal medicine, medicine, Hematology, medicine.disease, business, Metastatic breast cancer
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::3ae5fc739f1784c8e5f51b3dd87c1e79
https://doi.org/10.1016/j .annonc.2021.08.514 -
10
المؤلفون: Thomas Bachelot, Carole Bouleuc, Marie Ange Mouret-Reynier, V. Perotin, C. Courtinard, Simone Mathoulin-Pélissier, J C Eymard, Matthieu Frasca, Anthony Gonçalves, Christelle Levy
المصدر: European Journal of Public Health. 30
مصطلحات موضوعية: Oncology, medicine.medical_specialty, Palliative care, business.industry, Internal medicine, parasitic diseases, Cohort, Public Health, Environmental and Occupational Health, medicine, business, medicine.disease, Metastatic breast cancer
-
11
المؤلفون: M. Campone, A. Gonçalves, L. Roca, A Zingarello, Sofia Rivera, H. Roche, Bruno Coudert, J-C Eymard, S Delaloge, Chafika Mazouni, Jérôme Lemonnier, J-L Canon, C. Tunon de Lara, Thomas Bachelot, Magali Lacroix-Triki, PH Cottu, Thomas Filleron, Daniel Serin, Christine Levy, Barbara Pistilli, Thierry Petit
المصدر: Cancer Research. 78:P1-07
مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, business.industry, 10 year follow up, Node (networking), Overtime, Hormone receptor, Internal medicine, Distribution (pharmacology), Medicine, In patient, business
-
12
المؤلفون: A. Gonçalves, Christine Levy, J-M Ferrero, M. Campone, M. Leheurteur, M. Robain, Claudia Lefeuvre, Audrey Mailliez, Marc Debled, Lionel Uwer, PH Cottu, M-A Mouret-Reynier, Barbara Pistilli, J-C Eymard, William Jacot, Florence Dalenc, M. Chaix, C. Courtinard, P-E. Heudel, S Gourgou, Séverine Guiu, Julien Fraisse, Thierry Petit
المصدر: Cancer Research. 78:P6-14
مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, Chemotherapy, medicine.medical_specialty, business.industry, medicine.medical_treatment, Cancer, medicine.disease, Metastatic breast cancer, Clinical trial, 03 medical and health sciences, chemistry.chemical_compound, 030104 developmental biology, 0302 clinical medicine, Breast cancer, chemistry, 030220 oncology & carcinogenesis, Internal medicine, Propensity score matching, medicine, Clinical endpoint, business, Eribulin
-
13
المؤلفون: Ásgerður Sverrisdóttir, Gero Kramer, Aristotle Bamias, R. de Wit, Ayse Ozatilgan, Cora N. Sternberg, Bohuslav Melichar, M.C. Foster, J.S. de Bono, Roberto Iacovelli, Susan Feyerabend, Christian Wülfing, Carole Helissey, Christine Geffriaud-Ricouard, Bertrand Tombal, Daniel Castellano, Joan Carles, Christine Theodore, J.-C. Eymard, Karim Fizazi
المساهمون: Medical Oncology, Institut Català de la Salut, [de Wit R] Department of Medical Oncology, Erasmus Medical Center, Rotterdam, the Netherlands. [Wülfing C] Department of Urology, Asklepios Tumorzentrum, Hamburg, Germany. [Castellano D] Department of Medical Oncology, University Hospital 12 de Octubre, Madrid, Spain. [Kramer G] Department of Urology, Medical University of Vienna, Vienna, Austria. [Eymard JC] Department of Medical Oncology, Institute Jean Godinot, Reims, France. [Sternberg CN] Division of Hematology and Medical Oncology, Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, USA. [Carles J] Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus, UCL - SSS/IREC/CHEX - Pôle de chirgurgie expérimentale et transplantation, UCL - (SLuc) Service d'urologie
المصدر: ESMO Open, 6(5):100241. BMJ Publishing Group
Scientia
ESMO Open
ESMO open, Vol. 6, no. 5, p. 100241 [1-9] (2021)مصطلحات موضوعية: Male, Oncology, Cancer Research, Neutrophils, Other subheadings::Other subheadings::/drug therapy [Other subheadings], Prostate cancer, chemistry.chemical_compound, abiraterone, Antineoplastic Combined Chemotherapy Protocols, Medicine, Lymphocytes, prognostic factor, Original Research, enzalutamide, Hazard ratio, terapéutica::terapéutica::farmacoterapia::protocolos antineoplásicos::terapéutica::farmacoterapia::protocolos de quimioterapia antineoplásica combinada [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Prognosis, Prostatic Neoplasms, Castration-Resistant, Docetaxel, Cabazitaxel, Benzamides, Biomarker (medicine), Androstenes, Taxoids, medicine.drug, medicine.medical_specialty, Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], Quimioteràpia combinada, SDG 3 - Good Health and Well-being, neutrophil-to-lymphocyte ratio, Therapeutics::Therapeutics::Drug Therapy::Antineoplastic Protocols::Therapeutics::Drug Therapy::Antineoplastic Combined Chemotherapy Protocols [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], Internal medicine, Nitriles, Phenylthiohydantoin, Humans, Pròstata - Càncer - Prognosi, Enzalutamide, Neutrophil to lymphocyte ratio, Diagnosis::Prognosis [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], diagnóstico::pronóstico [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], business.industry, fungi, cabazitaxel, Pròstata - Càncer - Tractament, medicine.disease, Neoplasms::Neoplasms by Site::Urogenital Neoplasms::Genital Neoplasms, Male::Prostatic Neoplasms::Prostatic Neoplasms, Castration-Resistant [DISEASES], Confidence interval, metastatic castration-resistant prostate cancer, chemistry, neoplasias::neoplasias por localización::neoplasias urogenitales::neoplasias de los genitales masculinos::neoplasias de la próstata::neoplasias prostáticas resistentes a la castración [ENFERMEDADES], business
وصف الملف: application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4b88349c3a937b74a86f31dd44753d3
https://doi.org/10.1016/j .esmoop.2021.100241 -
14
المؤلفون: Antoine Thiery-Vuillemin, M. Chehimi, C. Quentric, Bérangère Narciso, J. Barthomeuf, Pierre Bigot, F. Schlürmann, L. Albiges, F. Calcagno, J.-C. Eymard, Philippe Barthélémy, Bernard Escudier, Yann-Alexandre Vano
المصدر: Annals of Oncology. 32:S697
مصطلحات موضوعية: medicine.medical_specialty, business.industry, Real world outcomes, Subgroup analysis, Hematology, medicine.disease, Oncology, Renal cell carcinoma, Concomitant, Internal medicine, medicine, Nivolumab, business, Baseline (configuration management)
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::3499adf8cb76fcdfee017c522d392250
https://doi.org/10.1016/j .annonc.2021.08.070 -
15
المؤلفون: Jozef Mardiak, Remy Delva, N. Naoun, J. P. Malhaire, Frederic Rolland, G. Le Teuff, S. Nenan, Stéphane Culine, Christine Chevreau, Lionnel Geoffrois, J.-C. Eymard, Gwenaelle Gravis, M. Reckova, Karim Fizazi, P. Kerbrat, Aude Flechon, Luigi Pagliaro, Guilhem Roubaud, Christine Theodore, Claude Linassier
المصدر: Annals of Oncology. 32:S719
مصطلحات موضوعية: Poor prognosis, chemistry.chemical_compound, Oncology, chemistry, Pulmonary toxicity, business.industry, Cancer research, medicine, Hematology, Germ cell tumors, medicine.disease, business, Bleomycin
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::a22f6baaeb3f9a998112777c692aa422
https://doi.org/10.1016/j .annonc.2021.08.109 -
16
المؤلفون: Anne-Laure Martin, Gwenaelle Gravis, J. P. Malhaire, G. Le Teuff, Frederic Rolland, J.-C. Eymard, M. Reckova, F. Journeau, Aude Flechon, Lance C. Pagliaro, Muriel Habibian, Jozef Mardiak, Stéphane Culine, Karim Fizazi, Christopher J. Logothetis, Yohann Loriot, P. Kerbrat, Christine Chevreau, Guilhem Roubaud, A. Laplanche, Remy Delva, Claude Linassier, Christine Theodore, Lionnel Geoffrois
المصدر: European Journal of Cancer. 87:140-146
مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Poor prognosis, Time Factors, medicine.medical_treatment, Radiography, Kaplan-Meier Estimate, Bleomycin, Disease-Free Survival, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Testicular Neoplasms, Risk Factors, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Multicenter Studies as Topic, Etoposide, Proportional Hazards Models, Retrospective Studies, Cisplatin, Chemotherapy, Brain Neoplasms, business.industry, Neoplasms, Germ Cell and Embryonal, Magnetic Resonance Imaging, United States, Surgery, Regimen, Treatment Outcome, 030104 developmental biology, medicine.anatomical_structure, Clinical Trials, Phase III as Topic, chemistry, 030220 oncology & carcinogenesis, Disease Progression, France, Tomography, X-Ray Computed, business, Germ cell, medicine.drug
-
17
المؤلفون: R. de Wit, Roberto Iacovelli, Christian Wülfing, Christine Theodore, Elizabeth M. Poole, Ayse Ozatilgan, Joan Carles, Christine Geffriaud-Ricouard, Bertrand Tombal, Carole Helissey, D. Castellano Gauna, Ásgerður Sverrisdóttir, Gero Kramer, Susan Feyerabend, Cora N. Sternberg, J.S. de Bono, Bohuslav Melichar, Karim Fizazi, Aristotle Bamias, J.-C. Eymard
المصدر: Annals of Oncology. 31:S519-S520
مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, Lymphocyte, Hematology, Castration resistant, medicine.disease, chemistry.chemical_compound, Abiraterone, Prostate cancer, medicine.anatomical_structure, chemistry, Cabazitaxel, Internal medicine, medicine, Enzalutamide, In patient, business, medicine.drug, Predictive biomarker
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::cf0df78ebd58c8f0b8896905872c41f9
https://doi.org/10.1016/j .annonc.2020.08.888 -
18
المؤلفون: Lionel Uwer, A. Gonçalves, A. Hennequin, C. Le Tourneau, Paul Gougis, Thomas Bachelot, C. Levy, Grégory Simon, William Jacot, Matthieu Carton, Corinne Tchokothe, M.-A. Mouret-Reynier, M. Saghatchian, Thierry Petit, Marc Debled, Christian Cailliot, M. Leheurteur, Audrey Mailliez, Christophe Perrin, M. Campone, Florence Dalenc, J.-C. Eymard, E. Chamorey
المساهمون: Centre d'investigation clinique Paris Est [CHU Pitié Salpêtrière] (CIC Paris-Est), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU), Institut Curie [Paris], CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Institut Curie - Saint Cloud (ICSC), Institut de Cancérologie de l'Ouest [Angers/Nantes] (UNICANCER/ICO), UNICANCER, Institut Claudius Regaud, Centre Régional de Lutte contre le Cancer Oscar Lambret [Lille] (UNICANCER/Lille), Université de Lille-UNICANCER, Centre Régional de Lutte contre le Cancer François Baclesse [Caen] (UNICANCER/CRLC), Normandie Université (NU)-UNICANCER-Tumorothèque de Caen Basse-Normandie (TCBN), Institut du Cancer de Montpellier (ICM), Institut Bergonié [Bordeaux], Centre de Lutte Contre le Cancer Henri Becquerel Normandie Rouen (CLCC Henri Becquerel), Centre Léon Bérard [Lyon], Centre Régional de Lutte contre le cancer Georges-François Leclerc [Dijon] (UNICANCER/CRLCC-CGFL), Centre Eugène Marquis (CRLCC), Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC), Institut de Cancérologie de Lorraine - Alexis Vautrin [Nancy] (UNICANCER/ICL), CRLCC Jean Godinot, Centre Paul Strauss, CRLCC Paul Strauss, Centre Jean Perrin [Clermont-Ferrand] (UNICANCER/CJP), Centre de Lutte contre le Cancer Antoine Lacassagne [Nice] (UNICANCER/CAL), UNICANCER-Université Côte d'Azur (UCA), R&D Unicancer [Paris], Cancer et génome: Bioinformatique, biostatistiques et épidémiologie d'un système complexe, Mines Paris - PSL (École nationale supérieure des mines de Paris), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Institut Curie [Paris]-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre d'investigation clinique pluridisciplinaire [CHU Pitié Salpêtrière] (CIC-P 1421), Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), CCSD, Accord Elsevier, Centre d'investigation clinique Paris Est (CIC Paris-Est), Institut Curie [Saint-Cloud], MINES ParisTech - École nationale supérieure des mines de Paris, Unité de Recherche sur les Maladies Cardiovasculaires, du Métabolisme et de la Nutrition = Institute of cardiometabolism and nutrition (ICAN), Université Pierre et Marie Curie - Paris 6 (UPMC)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière [AP-HP], Vieillissement et Maladies chroniques : approches épidémiologique et de santé publique (VIMA), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre de Recherche en Cancérologie Nantes-Angers (CRCNA), Centre Hospitalier Universitaire d'Angers (CHU Angers), PRES Université Nantes Angers Le Mans (UNAM)-PRES Université Nantes Angers Le Mans (UNAM)-Hôtel-Dieu de Nantes-Institut National de la Santé et de la Recherche Médicale (INSERM)-Hôpital Laennec-Centre National de la Recherche Scientifique (CNRS)-Faculté de Médecine d'Angers-Centre hospitalier universitaire de Nantes (CHU Nantes), Institut Universitaire du Cancer de Toulouse - Oncopole (IUCT Oncopole - UMR 1037), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-CHU Toulouse [Toulouse]-Institut National de la Santé et de la Recherche Médicale (INSERM), Bureau de Recherches Géologiques et Minières (BRGM) (BRGM), Centre Hospitalier Universitaire de Montpellier (CHU Montpellier ), Hydrosystèmes et Bioprocédés (UR HBAN), Institut national de recherche en sciences et technologies pour l'environnement et l'agriculture (IRSTEA), Nutrition, obésité et risque thrombotique (NORT), Institut National de la Recherche Agronomique (INRA)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM), CEA-Direction des Energies (ex-Direction de l'Energie Nucléaire) (CEA-DES (ex-DEN)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA), Imagerie Moléculaire et Stratégies Théranostiques (IMoST), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Clermont Auvergne [2017-2020] (UCA [2017-2020]), Biostatistics Unit, UNICANCER-Université Côte d'Azur (UCA)-UNICANCER-Université Côte d'Azur (UCA), Biologie et écologie tropicale et méditerranéenne [2007-2010] (BETM), Université de Perpignan Via Domitia (UPVD)-École pratique des hautes études (EPHE), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Centre National de la Recherche Scientifique (CNRS), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), Aix Marseille Université (AMU)-Institut National de la Recherche Agronomique (INRA)-Institut National de la Santé et de la Recherche Médicale (INSERM), Université Clermont Auvergne [2017-2020] (UCA [2017-2020])-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut Curie [Paris]-MINES ParisTech - École nationale supérieure des mines de Paris, Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Institut National de la Santé et de la Recherche Médicale (INSERM)
المصدر: The Breast
The Breast, 2020, 49, pp.17-24. ⟨10.1016/j.breast.2019.10.004⟩
Breast, Vol 49, Iss, Pp 17-24 (2020)
The Breast : official journal of the European Society of Mastologyمصطلحات موضوعية: Time Factors, Databases, Factual, [SDV]Life Sciences [q-bio], Estrogen receptor, Triple Negative Breast Neoplasms, Real-life data, computer.software_genre, Metastasis, 0302 clinical medicine, Breast cancer, Risk Factors, Epidemiology, 030212 general & internal medicine, Neoplasm Metastasis, skin and connective tissue diseases, Aged, 80 and over, Database, General Medicine, Middle Aged, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Metastatic breast cancer, Progression-Free Survival, 3. Good health, [SDV] Life Sciences [q-bio], 030220 oncology & carcinogenesis, Cohort, Original Article, Female, Metastatic recurrence, France, Adult, medicine.medical_specialty, Breast Neoplasms, [SDV.CAN]Life Sciences [q-bio]/Cancer, lcsh:RC254-282, 03 medical and health sciences, [SDV.CAN] Life Sciences [q-bio]/Cancer, Median follow-up, Biomarkers, Tumor, medicine, Humans, Aged, Retrospective Studies, Growth rate, business.industry, Cancer, medicine.disease, Survival Analysis, Surgery, Neoplasm Recurrence, Local, business, computer, Follow-Up Studies
وصف الملف: application/pdf
-
19
المؤلفون: G. Chenuc, Laurence Bozec, Jessy Delaye, Esma Saada, Sophie Piperno-Neumann, Florence Duffaud, I.L. Ray-Coquard, N. Isambert, Emmanuelle Bompas, Didier Cupissol, Christine Chevreau, J.-C. Eymard, C. Guillemet, Jacques-Olivier Bay, Maria Rios, Nicolas Penel, Antoine Italiano, François Bertucci, Corinne Delcambre, Patricia Pautier
المساهمون: Role of intra-Clonal Heterogeneity and Leukemic environment in ThErapy Resistance of chronic leukemias (CHELTER), Université Clermont Auvergne [2017-2020] (UCA [2017-2020])
المصدر: European Journal of Cancer
European Journal of Cancer, Elsevier, 2020, 125, pp.31-37. ⟨10.1016/j.ejca.2019.10.028⟩مصطلحات موضوعية: 0301 basic medicine, Oncology, Adult, Leiomyosarcoma, Male, Cancer Research, medicine.medical_specialty, Antimetabolites, Antineoplastic, Indazoles, Combination therapy, medicine.medical_treatment, Population, Phases of clinical research, Deoxycytidine, Pazopanib, 03 medical and health sciences, 0302 clinical medicine, Maintenance therapy, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, education, Trabectedin, ComputingMilieux_MISCELLANEOUS, Aged, Aged, 80 and over, Chemotherapy, education.field_of_study, Sulfonamides, business.industry, [SDV.MHEP.HEM]Life Sciences [q-bio]/Human health and pathology/Hematology, Middle Aged, Gemcitabine, 3. Good health, 030104 developmental biology, Pyrimidines, 030220 oncology & carcinogenesis, Female, business, medicine.drug
-
20
المؤلفون: Philippe Barthélémy, Laurence Albiges, J.-C. Eymard, Guillaume Mouillet, Bernard Escudier, C. Quentric, M. Chartier, Antoine Thiery-Vuillemin, Y. Vano, F. Schlürmann
المصدر: European Urology Open Science, Vol 21, Iss, Pp S182-(2020)
مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, Urology, Subgroup analysis, lcsh:Diseases of the genitourinary system. Urology, lcsh:RC870-923, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, lcsh:RC254-282, Renal cell carcinoma, Internal medicine, medicine, Nivolumab, business